AusBiotech

AusBiotech is pleased to continue its partnership with CSIRO, connecting the sector by delivering 2020’s first BioCheers events in Victoria, New South Wales, and Queensland during February.

Regenerative medicine is poised for continued expansion in 2020, after the latest global industry briefing reveals another year of significant growth, and total global financings the second highest yet.

AusBiotech has launched the 2020 CEO Industry Position Survey, asking leaders of biotechnology companies for their views and policy priorities of our Australian life sciences sector.

The TGA is seeking feedback on two consultations, into the guidelines for the export of therapeutic goods from Australia, and the proposed adoption or non-adoption of a multitude of EU and ICH guidelines.

The New Year has dawned with news that the strength and success of the biotech sector delivered over the past year, and continued over Christmas.

This year has seen another strong performance in biotech: AusBiotech advanced a resolute advocacy programme, saw a Federal election, engaged members and parliamentarians at a CEO Policy Forum where an Australian Biotechnology 2030 Plan was announced, and launched new quarterly policy updates.

AusBiotech and Medicines Australia are delighted to announce the annual NSW Women in Life Sciences Luncheon 2020 will be held in Sydney ahead of International Women’s Day, on 6 March 2020.

A final call has been made for nominations of leading science and technology entrepreneurs for the Clunies Ross Awards.

AusBiotech has released a new report illustrating for the first time the disproportionately-negative effects that the biotech sector faces above other innovative industries, by the proposed changes in the new Research and Development Tax Incentive (RDTI) Bill.

AusBiotech says it is 'astonished' with the federal government's plan to proceed with cuts to the R&D Tax incentive­ despite the findings of a Senate inquiry.

NSW Health’s Medical Devices Fund has opened its latest round, with $8 million available to support local innovation on its journey to market.

AusBiotech is calling for innovative approaches, contributions or analyses to include in their 2020 Australasian Biotechnology journals. AusBiotech is welcoming abstracts from valued members on medtech, digital health, and therapeutic trends and discoveries to illustrate the industry’s achievements and challenges being faced.